Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
4.700
-1.050 (-18.26%)
At close: Dec 19, 2025, 4:00 PM EST
4.750
+0.050 (1.06%)
After-hours: Dec 19, 2025, 6:40 PM EST
Evaxion Market Cap
Evaxion has a market cap or net worth of $39.2 million as of December 19, 2025. Its market cap has increased by 360.85% in one year.
Market Cap
39.20M
Enterprise Value
29.67M
1-Year Change
360.85%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $39.20M, a decrease of -79.58%. That is a compound annual growth rate of -27.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 47.96M | 867.02% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | 191.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 946.31B |
| Johnson & Johnson | 501.88B |
| AbbVie | 393.81B |
| UnitedHealth Group | 297.24B |
| AstraZeneca | 281.41B |
| Novartis AG | 260.53B |
| Merck & Co. | 249.91B |
| Abbott Laboratories | 217.56B |